Langerhans cells and more: Langerin-expressing dendritic cell subsets in the skin

Immunological Reviews

Volumn 234, Issue 1, 2010, Pages 120-141

  Romani, Nikolaus ^a   Clausen, Björn E ^b   Stoitzner, Patrizia ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Antigen presentation; Cell ablation; Dendritic cells; Immunogenicity; Langerhans cells; Langerin CD207

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AUTOANTIGEN; CD103 ANTIGEN; CD34 ANTIGEN; CD40 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR7; COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; DIPHTHERIA TOXIN; EPITHELIAL CELL ADHESION MOLECULE; FC RECEPTOR; GLYCOPROTEIN P 15095; GOLD CHLORIDE; HLA DR ANTIGEN; IKAROS TRANSCRIPTION FACTOR; INHIBITOR OF DIFFERENTIATION 2; INTERLEUKIN 10; LANGERIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN ANTIBODY; T6 ANTIGEN; TRANSCRIPTION FACTOR RELB; TRANSFORMING GROWTH FACTOR BETA; TUMOR VACCINE; UNINDEXED DRUG; VACCINE;

ADAPTIVE IMMUNITY; ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ATOPIC DERMATITIS; CELL FUNCTION; CELL GRANULE; CELL LINEAGE; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CELL SPECIFICITY; CELL STRUCTURE; CELL SUBPOPULATION; CELL SURFACE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG EFFICACY; DRUG TARGETING; EFFECTOR CELL; ELECTRON MICROSCOPY; ENZYME ACTIVITY; EPIDERMIS; GENE DELETION; GENETIC ENGINEERING; HISTIOCYTOSIS X; HISTORY OF MEDICINE; HOMEOSTASIS; HUMAN; HYPERSENSITIVITY; IMMUNE SYSTEM; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; INNATE IMMUNITY; LANGERHANS CELL; LEUKOCYTE; LYMPHOID ORGAN; MEDICAL RESEARCH; MONONUCLEAR PHAGOCYTE; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETICULOENDOTHELIOSIS; REVIEW; SKIN CELL; TUMOR IMMUNITY; TUMOR MODEL; VACCINATION; VIRUS INFECTION;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, SURFACE; CELL LINEAGE; COMMUNICABLE DISEASES; DERMATITIS, CONTACT; DISEASE MODELS, ANIMAL; HOMEOSTASIS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; LANGERHANS CELLS; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; MICE; MICE, TRANSGENIC; NEOPLASMS; OVALBUMIN; PHENOTYPE; SKIN; VACCINES;

EID: 77349112874     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2009.00886.x     Document Type: Review

References (221)

1. Steinman RM. Dendritic cells: versatile controllers of the immune system. Nat Med 2007 13 : 1155 1159.
2. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007 449 : 419 426.
3. Steinman RM, Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 2006 311 : 17 58.
4. Langerhans P. Über die Nerven der menschlichen Haut. Virchows Arch [A] 1868 44 : 325 337.
5. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973 137 : 1142 1162.
6. Schuler G, Steinman RM. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 1985 161 : 526 546. (Pubitemid 15142803)
7. Birbeck MS, Breathnach AS, Everall JD. An electron microscopic study of basal melanocytes and high level clear cells (Langerhans cell) in vitiligo. J Invest Dermatol 1961 37 : 51 64.
8. Basset F, Nezelof C, Turiaf J. Presence in electron microscopy of odd filamentous structures in pulmonary and osseous lesions of histiocytosis X. Current status of the question. Bull Mem Soc Med Hop Paris 1966 117 : 413 426.
9. Wolff K, Winkelmann RK. Ultrastructural localization of nucleoside triphosphatase in Langerhans cells. J Invest Dermatol 1967 48 : 50 54.
10. Stingl G, Wolff-Schreiner EC, Pichler WJ, Gschnait F, Knapp W. Epidermal Langerhans cells bear Fc and C3 receptors. Nature 1977 268 : 245 246.
11. Rowden G, Lewis MG, Sullivan AK. Ia antigen expression on human epidermal Langerhans cells. Nature 1977 268 : 247 248.
12. Klareskog L, Malmnas-Tjernlund U, Forsum U, Peterson PA. Epidermal Langerhans cells express Ia antigens. Nature 1977 268 : 248 250.
13. Katz SI, Tamaki K, Sachs DH. Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 1979 282 : 324 326.
14. Frelinger JG, Hood L, Hill S, Frelinger JA. Mouse epidermal Ia molecules have a bone marrow origin. Nature 1979 282 : 321 323.
15. Romani N, et al. Presentation of exogenous protein antigens by dendritic cells to T cell clones: intact protein is presented best by immature epidermal Langerhans cells. J Exp Med 1989 169 : 1169 1178.
16. Girolomoni G, Caux C, Lebecque S, Dezutter-Dambuyant C, Ricciardi-Castagnoli P. Langerhans cells: still a fundamental paradigm for studying the immunobiology of dendritic cells. Trends Immunol 2002 23 : 6 8.
17. Wilson NS, Villadangos JA. Lymphoid organ dendritic cells: beyond the Langerhans cells paradigm. Immunol Cell Biol 2004 82 : 91 98.
18. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 1992 360 : 258 261.
19. Valladeau J, et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 2000 12 : 71 81.
20. Valladeau J, et al. The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur J Immunol 1999 29 : 2695 2704.
21. Valladeau J, et al. Identification of mouse Langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues. J Immunol 2002 168 : 782 792.
22. Merad M, et al. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol 2002 3 : 1135 1141.
23. + dendritic cells but not by Langerhans cells. Science 2003 301 : 1925 1928.
24. Kissenpfennig A, et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 2005 22 : 643 654.
25. Bennett CL, et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 2005 169 : 569 576.
26. Kaplan DH, Jenison MC, Saeland S, Shlomchik WD, Shlomchik MJ. Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 2005 23 : 611 620.
27. + dendritic cells that develop and function independently of epidermal Langerhans cells. J Exp Med 2007 204 : 3119 3131.
28. Ginhoux F, et al. Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J Exp Med 2007 204 : 3133 3146.
29. + dendritic cells. J Exp Med 2007 204 : 3147 3156.
30. Bennett CL, Clausen BE. Dendritic cell ablation in mice: promises, pitfalls, and challenges. Trends Immunol 2007 28 : 525 531.
31. Kaplan DH, Kissenpfennig A, Clausen BE. Insights into Langerhans cell function from Langerhans cell ablation models. Eur J Immunol 2008 38 : 2369 2376.
32. + T cells by exogenous cell-associated antigens. Immunity 2002 17 : 211 220.
33. Iwasaki A. Mucosal dendritic cells. Annu Rev Immunol 2007 25 : 381 418.
34. Iijima N, Thompson JM, Iwasaki A. Dendritic cells and macrophages in the genitourinary tract. Mucosal Immunol 2008 1 : 451 459.
35. Allam JP, et al. Comparative analysis of nasal and oral mucosa dendritic cells. Allergy 2006 61 : 166 172.
36. Hellquist HB, Olsen KE, Irander K, Karlsson E, Odkvist LM. Langerhans cells and subsets of lymphocytes in the nasal mucosa. APMIS 1991 99 : 449 454.
37. Santoro A, et al. Recruitment of dendritic cells in oral lichen planus. J Pathol 2005 205 : 426 434.
38. Zavala WD, De Simone DS, Sacerdote FL, Cavicchia JC. Variation in Langerhans cell number and morphology between the upper and lower regions of the human esophageal epithelium. Anat Rec 2002 268 : 360 364.
39. Lucendo AJ, et al. Immunophenotypic characterization and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through stereology: an analysis of the cellular mechanisms of the disease and the immunologic capacity of the esophagus. Am J Surg Pathol 2007 31 : 598 606.
40. Flores-Langarica A, et al. Network of dendritic cells within the muscular layer of the mouse intestine. Proc Natl Acad Sci USA 2005 102 : 19039 19044.
41. Kaser A, et al. Increased expression of CCL20 in human inflammatory bowel disease. J Clin Immunol 2004 24 : 74 85. (Pubitemid 38375798)
42. Chang SY, et al. Lack of retinoic acid leads to increased langerin-expressing dendritic cells in gut-associated lymphoid tissues. Gastroenterology 2009 doi:.
43. Wieser F, Hosmann J, Tschugguel W, Czerwenka K, Sedivy R, Huber JC. Progesterone increases the number of Langerhans cells in human vaginal epithelium. Fertil Steril 2001 75 : 1234 1235.
44. Ildgruben AK, Sjoberg IM, Hammarstrom ML. Influence of hormonal contraceptives on the immune cells and thickness of human vaginal epithelium. Obstet Gynecol 2003 102 : 571 582.
45. Iijima N, Linehan MM, Saeland S, Iwasaki A. Vaginal epithelial dendritic cells renew from bone marrow precursors. Proc Natl Acad Sci USA 2007 104 : 19061 19066.
46. Sobhani I, et al. Anal carcinoma: incidence and effect of cumulative infections. AIDS 2004 18 : 1561 1569.
47. 7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J Immunol 2006 176 : 2161 2172.
48. Schon-Hegrad MA, Oliver J, McMenamin PG, Holt PG. Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatability complex antigen (Ia)-bearing dendritic cells (DCs) in the conducting airways. J Exp Med 1991 173 : 1345 1356.
49. Lambrecht BN, Hammad H. Biology of lung dendritic cells at the origin of asthma. Immunity 2009 31 : 412 424.
50. Mayer WJ, et al. Characterization of antigen-presenting cells in fresh and cultured human corneas using novel dendritic cell markers. Invest Ophthalmol Vis Sci 2007 48 : 4459 4467.
51. Valladeau J, Dezutter-Dambuyant C, Saeland S. Langerin/CD207 sheds light on formation of Birbeck granules and their possible function in Langerhans cells. Immunol Res 2003 28 : 93 107.
52. De Witte L, et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med 2007 13 : 367 371.
53. Uzan-Gafsou S, et al. Rab11A controls the biogenesis of Birbeck granules by regulating Langerin recycling and stability. Mol Biol Cell 2007 18 : 3169 3179.
54. Mc Dermott R, et al. Birbeck granules are subdomains of endosomal recycling compartment in human epidermal Langerhans cells, which form where langerin accumulates. Mol Biol Cell 2002 13 : 317 335.
55. Cheong C, et al. Production of monoclonal antibodies that recognize the extracellular domain of mouse Langerin/CD207. J Immunol Methods 2007 324 : 48 62.
56. Douillard P, et al. Mouse lymphoid tissue contains distinct subsets of Langerin/CD207+ dendritic cells, only one of which represents epidermal-derived Langerhans cells. J Invest Dermatol 2005 125 : 983 994.
57. Stoitzner P, Tripp CH, Douillard P, Saeland S, Romani N. Migratory Langerhans cells in mouse lymph nodes in steady state and inflammation. J Invest Dermatol 2005 125 : 116 125.
58. Kashihara M, Ueda M, Horiguchi Y, Furukawa F, Hanaoka M, Imamura S. A monoclonal antibody specifically reactive to human Langerhans cells. J Invest Dermatol 1986 87 : 602 612.
59. Lukas M, et al. Human cutaneous dendritic cells migrate through dermal lymphatic vessels in a skin organ culture model. J Invest Dermatol 1996 106 : 1293 1299.
60. Merad M, Ginhoux F, Collin M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol 2008 8 : 935 947.
61. Lenz A, Heine M, Schuler G, Romani N. Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J Clin Invest 1993 92 : 2587 2596.
62. Romani N, et al. Migration of dendritic cells into lymphatics - the Langerhans cell example: routes, regulation, and relevance. Int Rev Cytol 2001 207 : 237 270.
63. Stoitzner P, et al. Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207. J Invest Dermatol 2003 120 : 266 274.
64. Horton JJ, Allen MH, MacDonald DM. An assessment of Langerhans cell quantification in tissue sections. J Am Acad Dermatol 1984 11 : 591 593.
65. de Jong MCJM, Blanken R, Nanninga J, Van Voorst Vader PC, Poppema S. Defined in situ enumeration of T6 and HLA-DR expressing epidermal Langerhans cells: morphologic and methodologic aspects. J Invest Dermatol 1986 87 : 698 702.
66. Flacher V, et al. Epidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermis. J Invest Dermatol 2009 doi:.
67. Nagao K, et al. Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc Natl Acad Sci USA 2009 106 : 3312 3317.
68. Borkowski TA, Letterio JJ, Farr AG, Udey MC. A role for endogenous transforming growth factor β1 in Langerhans cell biology: the skin of transforming growth factor β1 null mice is devoid of epidermal Langerhans cells. J Exp Med 1996 184 : 2417 2422.
69. Merad M, Manz MG. Dendritic cell homeostasis. Blood 2009 113 : 3418 3427.
70. Romani N, Merad M, Stingl G, Stoitzner P. Langerhans cells at the interface of medicine, science, and industry. J Invest Dermatol 2010 130 : 331 335.
71. Ginhoux F, et al. Langerhans cells arise from monocytes in vivo. Nat Immunol 2006 7 : 265 273.
72. Randolph GJ, Ochando J, Partida-Sánchez S. Migration of dendritic cell subsets and their precursors. Annu Rev Immunol 2008 26 : 293 316.
73. Tripp CH, Sparber F, Hermans IF, Romani N, Stoitzner P. Glycolipids injected into the skin are presented to NKT cells in the draining lymph node independently of migratory skin dendritic cells. J Immunol 2009 182 : 7644 7654.
74. Henri S, et al. CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J Exp Med 2010 207 : 189 206.
75. Kel JM, Noordegraaf M, Girard-Madoux MJH, Reizis B, Clausen BE. TGF-β controls Langerhans cell homeostasis in the epidermis. 2010 (submitted).
76. Kaplan DH, Li MO, Jenison MC, Shlomchik WD, Flavell RA, Shlomchik MJ. Autocrine/paracrine TGFβ1 is required for the development of epidermal Langerhans cells. J Exp Med 2007 204 : 2545 2552.
77. McLellan AD, et al. Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression. Blood 2002 99 : 2084 2093.
78. Flacher V, et al. Expression of Langerin/CD207 reveals dendritic cell heterogeneity between inbred mouse strains. Immunology 2008 123 : 339 347.
79. Borkowski TA, Nelson AJ, Farr AG, Udey MC. Expression of gp40, the murine homologue of human epithelial cell adhesion molecule (Ep-CAM), by murine dendritic cells. Eur J Immunol 1996 26 : 110 114.
80. Geurtsvankessel CH, et al. Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells. J Exp Med 2008 205 : 1621 1634.
81. Bogunovic M, et al. Origin of the lamina propria dendritic cell network. Immunity 2009 31 : 513 525.
82. Helf J, et al. Origin and functional heterogeneity of non-lymphoid tissue dendritic cells in mice. Immunol Rev 2010 234 : 55 75.
83. Ginhoux F, et al. The origin and development of nonlymphoid tissue CD103+ DCs. J Exp Med 2009 206 : 3115 3130.
84. Henri S, et al. The dendritic cell populations of mouse lymph nodes. J Immunol 2001 167 : 741 748.
85. Idoyaga J, Suda N, Suda K, Park CG, Steinman RM. Antibody to Langerin/CD207 localizes large numbers of CD8alpha+ dendritic cells to the marginal zone of mouse spleen. Proc Natl Acad Sci USA 2009 106 : 1524 1529.
86. - dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med 2000 192 : 1685 1695.
87. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med 1999 189 : 587 592.
88. Macatonia SE, Knight SC, Edwards AJ, Griffiths S, Fryer P. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. J Exp Med 1987 166 : 1654 1667.
89. Schuler G, Romani N, Stössel H, Wolff K. Structural organization and biological properties of Langerhans cells. In : Schuler G ed. Epidermal Langerhans Cells. Boca Raton, FL : CRC Press Inc, 1991 : 87 137.
90. Shamoto M, Shinzato M, Hosokawa S, Kaneko C, Hakuno T, Nomoto K. Langerhans cells in the lymph node: mirror section and immunoelectron microscopic studies. Virchows Arch B Cell Pathol Incl Mol Pathol 1992 61 : 337 341.
91. Vernon ML, Fountain L, Krebs HM, Horta-Barbosa L, Fuccillo DA, Sever JL. Birbeck granules (Langerhans' cell granules) in human lymph nodes. Am J Clin Pathol 1973 60 : 771 779.
92. Geissmann F, et al. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J Exp Med 2002 196 : 417 430.
93. Angel CE, et al. Distinctive localization of antigen-presenting cells in human lymph nodes. Blood 2009 113 : 1257 1267.
94. + dendritic epidermal cells in the perinatal period. J Immunol 1989 143 : 2431 2438.
95. Romani N, Schuler G, Fritsch PO. The ontogeny of Ia-positive and Thy-1 positive leukocytes of murine epidermis. J Invest Dermatol 1986 86 : 129 133.
96. Tripp CH, et al. Ontogeny of Langerin/CD207 expression in the epidermis of mice. J Invest Dermatol 2004 122 : 670 672.
97. Chorro L, et al. Langerhans cell (LCs) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LCs network. J Exp Med 2009 206 : 3089 3100.
98. Chang-Rodriguez S, Hoetzenecker W, Schwärzler C, Biedermann T, Saeland S, Elbe-Bürger A. Fetal and neonatal murine skin harbors Langerhans cell precursors. J Leukoc Biol 2005 77 : 352 360.
99. Dewar AL, Doherty KV, Woods GM, Lyons AB, Muller HK. Acquisition of immune function during the development of the Langerhans cell network in neonatal mice. Immunology 2001 103 : 61 69.
100. Holzmann S, et al. A model system using tape stripping for characterization of Langerhans cell-precursors in vivo. J Invest Dermatol 2004 122 : 1165 1174.
101. Foster CA. Ontogeny of Langerhans cells in human embryonic and fetal skin: expression of HLA-DR and OKT-6 determinants. J Invest Dermatol 1986 86 : 240 243.
102. Foster CA, Holbrook KA. Ontogeny of Langerhans cells in human embryonic and fetal skin: cell densities and phenotypic expression relative to epidermal growth. Am J Anat 1989 184 : 157 164.
103. Schuster C, et al. HLA-DR+ leukocytes acquire CD1 antigens in embryonic and fetal human skin and contain functional antigen-presenting cells. J Exp Med 2009 206 : 169 181.
104. Pelletier M, Perreault C, Landry D, David M, Montplaiser S. Ontogeny of human epidermal Langerhans cells. Transplantation 1984 38 : 544 546.
105. Krueger GG, Daynes RA, Emam M. Biology of Langerhans cells: selective migration of Langerhans cells into allogeneic and xenogeneic grafts on nude mice. Proc Natl Acad Sci USA 1983 80 : 1650 1654.
106. Kanitakis J, Petruzzo P, Dubernard JM. Turnover of epidermal Langerhans' cells. N Engl J Med 2004 351 : 2661 2662.
107. Miyauchi S, Hashimoto K. Mitotic activities of normal epidermal Langerhans cells. J Invest Dermatol 1989 92 : 120 121.
108. Konrad K, Hönigsmann H. Elektronenmikroskopischer Nachweis einer mitotischen Langerhanszelle in normaler menschlicher Epidermis/electron microscopic demonstration of a mitotic Langerhans cell in the normal human epidermis. Arch Dermatol Res 1973 246 : 70 76.
109. Breathnach SM. Origin, cell lineage, ontogeny, tissue distribution and kinetics of Langerhans cells. In : Schuler G, ed. Epidermal Langerhans Cells. Boca Raton, FL : CRC Press Inc., 1991 : 23 47.
110. Kamath AT, Henri S, Battye F, Tough DF, Shortman K. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 2002 100 : 1734 1741.
111. Ghaznawie M, Papadimitriou JM, Heenan PJ. The steady-state turnover of murine epidermal Langerhans cells. Br J Dermatol 1999 141 : 57 61.
112. Holt PG, Haining S, Nelson DJ, Sedgwick JD. Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J Immunol 1994 153 : 256 261.
113. Weinlich G, et al. Entry into afferent lymphatics and maturation in situ of migrating cutaneous dendritic cells. J Invest Dermatol 1998 110 : 441 448.
114. Palucka AK, Banchereau J. Langerhans cells: daughters of monocytes. Nat Immunol 2006 7 : 223 224.
115. Murphy GF, Messadi D, Fonferko E, Hancock WW. Phenotypic transformation of macrophages to Langerhans cells in the skin. Am J Pathol 1986 123 : 401 406.
116. Geissmann F, Prost C, Monnet JP, Dy M, Brousse N, Hermine O. Transforming growth factor β1 in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med 1998 187 : 961 966.
117. Meindl S, Schmidt U, Vaculik C, Elbe-Bürger A. Characterization, isolation, and differentiation of murine skin cells expressing hematopoietic stem cell markers. J Leukoc Biol 2006 80 : 816 826.
118. Borkowski TA, et al. A role for TGFβ1 in Langerhans cell biology - further characterization of the epidermal Langerhans cell defect in TGFβ1 null mice. J Clin Invest 1997 100 : 575 581.
119. Hacker C, et al. Transcriptional profiling identifies Id2 function in dendritic cell development. Nat Immunol 2003 4 : 380 386.
120. Fainaru O, et al. Runx3 regulates mouse TGF-β-mediated dendritic cell function and its absence results in airway inflammation. EMBO J 2004 23 : 969 979.
121. Strobl H, et al. flt3 ligand in cooperation with transforming growth factor-β1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions. Blood 1997 90 : 1425 1434.
122. Heinz LX, et al. Differential involvement of PU.1 and Id2 downstream of TGF-beta1 during Langerhans-cell commitment. Blood 2006 107 : 1445 1453.
123. Rathinam C, et al. The transcriptional repressor Gfi1 controls STAT3-dependent dendritic cell development and function. Immunity 2005 22 : 717 728.
124. Schiavoni G, et al. ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells. Blood 2004 103 : 2221 2228.
125. Zenke M, Hieronymus T. Towards an understanding of the transcription factor network of dendritic cell development. Trends Immunol 2006 27 : 140 145.
126. Heufler C, Koch F, Schuler G. Granulocyte-macrophage colony-stimulating factor and interleukin-1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 1988 167 : 700 705.
127. Witmer-Pack MD, Olivier W, Valinsky J, Schuler G, Steinman RM. Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J Exp Med 1987 166 : 1484 1498.
128. Mommaas AM, et al. Distribution of HLA class II molecules in epidermal Langerhans cells in situ. Eur J Immunol 1995 25 : 520 525.
129. Pierre P, et al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 1997 388 : 787 792.
130. Tang A, Amagai M, Granger LG, Stanley JR, Udey MC. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 1993 361 : 82 85.
131. Stoitzner P, Pfaller K, Stössel H, Romani N. A close-up view of migrating Langerhans cells in the skin. J Invest Dermatol 2002 118 : 117 125.
132. Kämpgen E, et al. Class II major histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture. Proc Natl Acad Sci USA 1991 88 : 3014 3018.
133. Stössel H, et al. Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells. J Exp Med 1990 172 : 1471 1482.
134. Stingl G, Katz SI, Clements L, Green I, Shevach EM. Immunologic functions of Ia-bearing epidermal Langerhans cells. J Immunol 1978 121 : 2005 2013.
135. Pehamberger H, Stingl LA, Pogantsch S, Steiner G, Wolff K, Stingl G. Epidermal cell-induced generation of cytotoxic T-lymphocyte responses against alloantigens or TNP-modified syngeneic cells: requirement for Ia-positive Langerhans cells. J Invest Dermatol 1983 81 : 208 211.
136. Braathen LR, Thorsby E. Studies on human epidermal Langerhans cells. I. Allo-activating and antigen-presenting capacity. Scand J Immunol 1980 11 : 401 408. (Pubitemid 10098957)
137. Stoitzner P, et al. Langerhans cells cross-present antigen derived from skin. Proc Natl Acad Sci USA 2006 103 : 7783 7788.
138. Klechevsky E, et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 2008 29 : 497 510.
139. Bedoui S, et al. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat Immunol 2009 10 : 488 495.
140. Enk AH, Angeloni VL, Udey MC, Katz SI. Inhibition of Langerhans cell antigen-presenting function by IL-10: a role for IL-10 in induction of tolerance. J Immunol 1993 151 : 2390 2398.
141. Jiang A, et al. Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 2007 27 : 610 624.
142. Blauvelt A, Katz SI, Udey MC. Human Langerhans cells express E-cadherin. J Invest Dermatol 1995 104 : 293 296.
143. Schwarzenberger K, Udey MC. Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J Invest Dermatol 1996 106 : 553 558.
144. Riedl E, Stöckl J, Majdic O, Scheinecker C, Knapp W, Strobl H. Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation. Blood 2000 96 : 4276 4284.
145. Hawiger D, et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001 194 : 769 779.
146. + T cell tolerance. J Exp Med 2002 196 : 1627 1638.
147. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003 21 : 685 711.
148. Silberberg I. Apposition of mononuclear cells to Langerhans cells in contact allergic reactions. An ultrastructural study. Acta Derm Venereol 1973 53 : 1 12.
149. Nestle FO, Zheng X-G, Thompson CB, Turka LA, Nickoloff BJ. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J Immunol 1993 151 : 6535 6545.
150. + cells are capable of initiating delayed type hypersensitivity responses. J Invest Dermatol 1990 94 : 267 272.
151. Schwarz A, Maeda A, Kernebeck K, Van Steeg H, Beissert S, Schwarz T. Prevention of UV radiation-induced immunosuppression by IL-12 is dependent on DNA repair. J Exp Med 2005 201 : 173 179.
152. Grabbe S, Steinbrink K, Steinert M, Luger TA, Schwarz T. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. J Immunol 1995 155 : 4207 4217.
153. Sullivan S, Bergstresser PR, Tigelaar R, Streilein JW. Induction and regulation of contact hypersensitivity by resident, bone marrow-derived, dendritic epidermal cells: Langerhans cells and Thy-1+ epidermal cells. J Immunol 1986 137 : 2460 2467.
154. Bacci S, Alard P, Dai RP, Nakamura T, Streilein JW. High and low doses of haptens dictate whether dermal or epidermal antigen-presenting cells promote contact hypersensitivity. Eur J Immunol 1997 27 : 442 448.
155. Bennett CL, Noordegraaf M, Martina CAE, Clausen BE. Langerhans cells are required for efficient presentation of topically applied hapten to T cells. J Immunol 2007 179 : 6830 6835.
156. Noordegraaf M, Flacher V, Stoitzner P, Clausen BE. Functional redundancy of Langerhans cells and Langerin+ dermal dendritic cells in contact hypersensitivity. 2010 in press).
157. Wang L, Bursch LS, Kissenpfennig A, Malissen B, Jameson SC, Hogquist KA. Langerin expressing cells promote skin immune responses under defined conditions. J Immunol 2008 180 : 4722 4727.
158. Igyarto BZ, et al. Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans cell-derived IL-10. J Immunol 2009 183 : 5085 5093.
159. Obhrai JS, et al. Langerhans cells are not required for efficient skin graft rejection. J Invest Dermatol 2008 128 : 1950 1955.
160. Wang L, Jameson SC, Hogquist KA. Epidermal Langerhans cells are not required for UV-induced immunosuppression. J Immunol 2009 183 : 5548 5553.
161. Schwarz A, Noordegraaf M, Maeda A, Torii K, Clausen BE, Schwarz T. Langerhans cells are required for UVR-induced immunosuppression. J Invest Dermatol 2010 doi:.
162. Holcmann M, et al. Skin inflammation is not sufficient to break tolerance induced against a novel antigen. J Immunol 2009 183 : 1133 1143.
163. Azukizawa H, et al. Induction of T-cell-mediated skin disease specific for antigen transgenically expressed in keratinocytes. Eur J Immunol 2003 33 : 1879 1888.
164. Shibaki A, Sato A, Vogel JC, Miyagawa F, Katz SI. Induction of GVHD-like skin disease by passively transferred T cell receptor transgenic CD8+ T cells into keratin-14-ovalbumin transgenic mice. J Invest Dermatol 2004 123 : 109 115.
165. McGargill MA, et al. A spontaneous CD8 T cell-dependent autoimmune disease to an antigen expressed under the human keratin 14 promoter. J Immunol 2003 169 : 2141 2147.
166. Kurts C, Heath WR, Carbone FR, Allison J, Miller JF, Kosaka H. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med 1996 184 : 923 930.
167. Bianchi T, et al. Maintenance of peripheral tolerance through controlled tissue homing of antigen-specific T cells in K14-mOVA mice. J Immunol 2009 182 : 4665 4674.
168. Choi JH, et al. Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves. J Exp Med 2009 206 : 497 505.
169. Kim BS, Miyagawa F, Cho YH, Bennett CL, Clausen BE, Katz SI. Keratinocytes function as accessory cells for presentation of endogenous antigen expressed in the epidermis. J Invest Dermatol 2009 129 : 2805 2817.
170. Mayerova D, Parke EA, Bursch LS, Odumade OA, Hogquist KA. Langerhans cells activate naïve self-antigen specific CD8 T cells in the steady state. Immunity 2004 21 : 391 400.
171. Aberer W, Kruisbeek AM, Shimada S, Katz SI. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells. J Immunol 1986 136 : 830 836.
172. Grubauer G, Romani N, Kofler H, Stanzl U, Fritsch P, Hintner H. Apoptotic keratin bodies as autoantigen causing the production of IgM-anti-keratin intermediate filament autoantibodies. J Invest Dermatol 1986 87 : 466 471.
173. Nikolic-Zugic J, Carbone FR. The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb-restricted ovalbumin determinant. Eur J Immunol 1990 20 : 2431 2437.
174. Stoitzner P, et al. Tumor immunotherapy by epicutaneous immunization requires Langerhans cells. J Immunol 2008 180 : 1991 1998.
175. Waithman J, et al. Skin-derived dendritic cells can mediate deletional tolerance of class I-restricted self-reactive T cells. J Immunol 2007 179 : 4535 4541.
176. Bursch LS, Rich BE, Hogquist KA. Langerhans cells are not required for the CD8 T cell response to epidermal self-antigens. J Immunol 2009 182 : 4657 4664.
177. Allan RS, et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006 25 : 153 162.
178. Zhao XY, et al. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective th1 responses to herpes simplex virus-2. J Exp Med 2003 197 : 153 162.
179. Jones CA, et al. Herpes simplex virus type 2 induces rapid cell death and functional impairment of murine dendritic cells in vitro. J Virol 2003 77 : 11139 11149.
180. Bosnjak L, Miranda-Saksena M, Koelle DM, Boadle RA, Jones CA, Cunningham AL. Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells. J Immunol 2005 174 : 2220 2227.
181. He Y, Zhang J, Donahue C, Falo LD Jr. Skin-derived dendritic cells Induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization. Immunity 2006 24 : 643 656.
182. Carbone FR, Belz GT, Heath WR. Transfer of antigen between migrating and lymph node-resident DCs in peripheral T-cell tolerance and immunity. Trends Immunol 2004 25 : 655 658.
183. Heath WR, et al. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 2004 199 : 9 26.
184. Galibert L, et al. Nectin-like protein 2 defines a subset of T-cell zone dendritic cells and is a ligand for class-I-restricted T-cell-associated molecule. J Biol Chem 2005 280 : 21955 21964.
185. Caminschi I, Lahoud MH, Shortman K. Enhancing immune responses by targeting antigen to DCs. Eur J Immunol 2009 39 : 931 938.
186. Ritter U, Osterloh A. A new view on cutaneous dendritic cell subsets in experimental leishmaniasis. Med Microbiol Immunol (Berl) 2007 196 : 51 59.
187. Moll H, Fuchs H, Blank C, Röllinghoff M. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur J Immunol 1993 23 : 1595 1601.
188. Ritter U, Meissner A, Scheidig C, Körner H. CD8α- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis. Eur J Immunol 2004 34 : 1542 1550.
189. Brewig N, et al. Priming of CD8+ and CD4+ T cells in experimental leishmaniasis is initiated by different dendritic cell subtypes. J Immunol 2009 182 : 774 783.
190. Ratzinger G, et al. Mature human Langerhans cells derived from CD34+ hemopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells. J Immunol 2004 173 : 2780 2791.
191. Cao T, Ueno H, Glaser C, Fay JW, Palucka AK, Banchereau J. Both Langerhans cells and interstitial DCs cross-present melanoma antigens and efficiently activate antigen-specific CTL. Eur J Immunol 2007 37 : 2657 2667.
192. Huijbers IJ, et al. An inducible mouse model of melanoma expressing a defined tumor antigen. Cancer Res 2006 66 : 3278 3286.
193. Frese KK, Tuveson DA. Maximizing mouse cancer models. Nat Rev Cancer 2007 7 : 645 658.
194. Pollock PM, et al. Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet 2003 34 : 108 112.
195. Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp Med 2003 198 : 267 279.
196. Strid J, et al. Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nat Immunol 2008 9 : 146 154.
197. Bogunovic M, et al. Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men. J Exp Med 2006 203 : 2627 2638.
198. Nichols LA, Chen Y, Colella TA, Bennett CL, Clausen BE, Engelhard VH. Deletional self-tolerance to a melanocyte/melanoma antigen derived from tyrosinase is mediated by a radio-resistant cell in peripheral and mesenteric lymph nodes. J Immunol 2007 179 : 993 1003.
199. Loser K, et al. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 2007 12 : 1372 1379.
200. Shklovskaya E, Roediger B, Fazekas de St GB. Epidermal and dermal dendritic cells display differential activation and migratory behavior while sharing the ability to stimulate CD4+ T cell proliferation in vivo. J Immunol 2008 181 : 418 430.
201. Heath WR, Carbone FR. Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat Immunol 2009 10 : 1237 1244.
202. Weitzman S, Egeler RM. Langerhans cell histiocytosis: update for the pediatrician. Curr Opin Pediatr 2008 20 : 23 29.
203. Rolland A, et al. Increased blood myeloid dendritic cells and dendritic cell-poietins in Langerhans cell histiocytosis. J Immunol 2005 174 : 3067 3071.
204. Coury F, et al. Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat Med 2008 14 : 81 87.
205. Senechal B, et al. Expansion of regulatory T cells in patients with Langerhans cell histiocytosis. PLoS Med 2007 4 : e253 1374 1384.
206. Steiner QG, et al. In vivo transformation of mouse conventional CD8alpha+ dendritic cells leads to progressive multisystem histiocytosis. Blood 2008 111 : 2073 2083.
207. Soumelis V, Liu YJ. Human thymic stromal lymphopoietin: A novel epithelial cell-derived cytokine and a potential key player in the induction of allergic inflammation. Springer Semin Immunopathol 2004 25 : 325 333. (Pubitemid 38296940)
208. Ebner S, et al. Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen presenting cells that induce pro-allergic T cells. J Allergy Clin Immunol 2007 119 : 982 990.
209. Li M, Hener P, Zhang Z, Kato S, Metzger D, Chambon P. Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc Natl Acad Sci USA 2006 103 : 11736 11741.
210. Elentner A, Finke D, Schmuth M, et al. Langerhans cells are critical in the development of atopic dermatitis-like inflammation and symptoms in mice. J Cell Mol Med 2009 doi:.
211. Hladik F, McElrath MJ. Setting the stage: host invasion by HIV. Nat Rev Immunol 2008 8 : 447 457.
212. de Jong MA, Geijtenbeek TB. Human immunodeficiency virus-1 acquisition in genital mucosa: Langerhans cells as key-players. J Intern Med 2009 265 : 18 28.
213. Wilflingseder D, et al. IgG opsonization of HIV impedes provirus formation in and infection of dendritic cells and subsequent long-term transfer to T cells. J Immunol 2007 178 : 7840 7848.
214. Benyo Z, Gille A, Bennett CL, Clausen BE, Offermanns S. Nicotinic acid-induced flushing is mediated by activation of epidermal Langerhans cells. Mol Pharmacol 2006 70 : 1844 1849.
215. Bonifaz LC, et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med 2004 199 : 815 824.
216. Boscardin SB, et al. Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. J Exp Med 2006 203 : 599 606.
217. Bozzacco L, et al. DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes. Proc Natl Acad Sci USA 2007 104 : 1289 1294.
218. Dudziak D, et al. Differential antigen processing by dendritic cell subsets in vivo. Science 2007 315 : 107 111.
219. Steinman RM. Dendritic cells in vivo: a key target for a new vaccine science. Immunity 2008 29 : 319 324.
220. Idoyaga J, et al. The Langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and MHC II products in vivo. J Immunol 2008 180 : 3647 3650.
221. Merad M, Romani N, Randolph GJ. Langerhans cells at the interface of medicine, science, and industry. J Invest Dermatol 2008 128 : 251 255.